Therefore, on the basis of these results, the possibility of new cancer development and cancer metastasis in patients undergoing long-term treatment with antiplatelet agents can be investigated to confirm the level of the secretory protein PAI-1 [28], as well as to explore ways to eliminate the side effects of these agents. The gene discussed is SERPINE1; the disease is cancer.